The global Wilms tumor protein market is estimated to be valued at US$2.92 billion in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Wilms tumor protein is an essential biomarker used for the detection and diagnosis of Wilms tumor, a type of kidney cancer that primarily...